| PRECLINICAL | evidence | Evaluation and Management of Hypoactive Sexual Desire Disorder. | Bremelanotide | — | 2018-06-01 |
| PRECLINICAL | evidence | Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options. | Bremelanotide | Sexual function & libido | 2017-12-01 |
| PRECLINICAL | evidence | Sexual arousal: Sex matters. | Bremelanotide | Sexual function & libido | 2017-10-04 |
| PRECLINICAL | evidence | Flibanserin for hypoactive sexual desire disorder: place in therapy. | Bremelanotide | — | 2017-01-01 |
| PRECLINICAL | evidence | Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder. | Bremelanotide | — | 2017-01-01 |
| PRECLINICAL | evidence | Re: Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial. | Bremelanotide | Sexual function & libido | 2016-11-01 |
| PRECLINICAL | evidence | Antagonistic Activities of Novel Peptides from Bacillus amyloliquefaciens PT14 against Fusarium solani and Fusarium oxysporum. | PT141 | — | 2015-12-09 |
| PRECLINICAL | evidence | The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder. | Bremelanotide | Sexual function & libido | 2015-11-01 |
| PRECLINICAL | evidence | Drugs in early clinical development for the treatment of female sexual dysfunction. | Bremelanotide | Sexual function & libido | 2015-02-01 |
| PRECLINICAL | evidence | Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies. | Bremelanotide | Sexual function & libido | 2014-11-01 |
| PRECLINICAL | evidence | [2013 annual meeting of the International Society for the Study of Women's Sexual Health (ISSWSH), 28 February-3 March 2013, New Orleans, Louisiana, USA. State of pharmacologial research in Women's Sexual Medicine: From testosterone to bremelatonide]. | Bremelanotide | Sexual function & libido | 2013-05-01 |
| PRECLINICAL | evidence | Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health. | Bremelanotide | — | 2013-04-01 |
| PRECLINICAL | evidence | Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. | Bremelanotide | Pigmentation | 2012-12-01 |
| PRECLINICAL | evidence | Bremelanotide. | Bremelanotide | — | 2012-01-01 |
| PRECLINICAL | evidence | Central nervous system agents and erectile dysfunction. | Bremelanotide | Sexual function & libido | 2011-05-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | Bremelanotide | — | 2008-10-01 |
| PRECLINICAL | evidence | Clinical applications of centrally acting agents in male sexual dysfunction. | Bremelanotide | Sexual function & libido | 2008-07-01 |
| PRECLINICAL | evidence | Preclinical effects of melanocortins in male sexual dysfunction. | Bremelanotide | Sexual function & libido | 2008-07-01 |
| PRECLINICAL | evidence | Central nervous system-acting agents and the treatment of erectile and sexual dysfunction. | Bremelanotide | Sexual function & libido | 2007-11-01 |
| PRECLINICAL | evidence | Centrally acting mechanisms for the treatment of male sexual dysfunction. | Bremelanotide | — | 2007-11-01 |
| PRECLINICAL | evidence | Clinical application of CNS-acting agents in FSD. | Bremelanotide | Sexual function & libido | 2007-11-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | Bremelanotide | — | 2007-10-01 |
| PRECLINICAL | evidence | Melanocortins in the treatment of male and female sexual dysfunction. | PT 141 | Sexual function & libido | 2007-01-01 |
| PRECLINICAL | evidence | Melanocortin receptors, melanotropic peptides and penile erection. | PT 141 | Sexual function & libido | 2007-01-01 |
| PRECLINICAL | evidence | Pharmaceutical aphrodisia. | Bremelanotide | Sexual function & libido | 2007-01-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | Bremelanotide | — | 2006-12-01 |
| PRECLINICAL | evidence | Bremelanotide: the female Viagra? | Bremelanotide | — | 2006-07-01 |
| PRECLINICAL | evidence | Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. | PT 141 | — | 2006-04-01 |
| PRECLINICAL | evidence | Bremelanotide. | Vyleesi | — | 2006-01-01 |
| PRECLINICAL | evidence | Gateways to clinical trials. | PT 141 | — | 2005-12-01 |
| PRECLINICAL | evidence | Control of penile erection by the melanocortinergic system: experimental evidences and therapeutic perspectives. | Bremelanotide | Sexual function & libido | 2004-09-01 |
| PRECLINICAL | evidence | PT-141 Palatin. | PT 141 | Sexual function & libido | 2004-04-01 |
| PRECLINICAL | evidence | [Therapy of erectile dysfunction in 2005]. | PT 141 | Sexual function & libido | 2003-10-01 |
| PRECLINICAL | evidence | Epidemiological markers of Salmonella typhimurium isolates in Rome. | PT141 | — | 1992-08-01 |
| INDEPENDENT-REVIEW | review | Bremelanotide (Vyleesi, PT-141) experiences?
I bought a 10mg vial the last time I picked up some other peptides because it was relatively cheap and I was curious. I've done a good amount of reading but not a lot of personal stories. I just took 1.25mg and I'm waiting for it to kick in, anybody tried it before? | COMMUNITY | — | 2025-10-12 |
| INDEPENDENT-REVIEW | review | Bremelanotide PT-141 | COMMUNITY | — | 2025-08-12 |
| EXPERT-COMMENTARY | mention | Bremelanotide's Slow Six-Hour Window #Shorts | Repose App | Peptide Calculator | Unclassified | 2026-07-24 |
| EXPERT-COMMENTARY | mention | Is PT-141 Worth It? A Critical Look at Bremelanotide | Peptide Corner | Unclassified | 2026-07-22 |
| EXPERT-COMMENTARY | mention | PT-141 Explained. | MWpeps | Unclassified | 2026-07-15 |
| EXPERT-COMMENTARY | mention | What is PT-141 (bremelanotide)? (Shorts) | PeptideClear Uk | Unclassified | 2026-07-10 |
| EXPERT-COMMENTARY | mention | Peptides for Low Libido? The Honest Truth Nobody Tells You | Dr. Holly Wood PhD, LMFT, CST | Unclassified | 2026-07-07 |
| EXPERT-COMMENTARY | mention | PT-141: The Desire-Circuit Peptide | Praxis Peptide Institute | Unclassified | 2026-07-04 |
| EXPERT-COMMENTARY | mention | Take control of your desire on your terms. | Vyleesi® (Bremelanotide Injection) | Unclassified | 2026-06-16 |
| EXPERT-COMMENTARY | mention | Where did your desire go? | Vyleesi® (Bremelanotide Injection) | Unclassified | 2026-06-16 |
| EXPERT-COMMENTARY | mention | Nasal Spray for Erectile Dysfunction — A Urologist Gives You the Honest Clinical Picture | Dr. Elizabeth Kavaler | Unclassified | 2026-06-07 |
| EXPERT-COMMENTARY | mention | The Peptide That Fixes What Sildenafil Cannot | Wright Lifestyle and Fitness | Unclassified | 2026-06-05 |
| EXPERT-COMMENTARY | mention | Low Libido in Women? Understanding Vyleesi with Sexual Health Experts | UroNurse | Unclassified | 2026-06-03 |
| EXPERT-COMMENTARY | mention | Unlocking Sexual Health: All About PT-141 Explained #shorts | Arego Brands | Unclassified | 2026-06-02 |
| EXPERT-COMMENTARY | mention | Bremelanotide (PT-141): Boost Libido & Erections Explained #shorts | Arego Brands | Unclassified | 2026-05-28 |
| EXPERT-COMMENTARY | mention | Bremelanotide: The New Solution for Sexual Desire #shorts | Arego Brands | Unclassified | 2026-05-28 |